Not investment advice. Educational platform. See Disclaimer.
NYSE: MRK
Merck & Co., Inc.
Healthcare | Drug Manufacturers - General
$151.64as of 2026-09-03 10:25 UTC
Market Cap$380.2B
Volume8.76M
EPS (TTM)$7.28
Merck & Co., Inc. (NYSE: MRK) is a $380.2B drug manufacturers - general company trading at $151.64 — 20.8× trailing earnings, yielding 2.15%. Figures from SEC EDGAR and market feeds; updated 2026-09-03 10:25 UTC.
52-Week Range
Low $107.90High $156.91
What Merck & Co., Inc. does
Merck is a global health care company operating two main business segments: Pharmaceutical and Animal Health. The Pharmaceutical segment produces prescription medicines, biologic therapies, and vaccines for human diseases, sold to drug wholesalers, retailers, hospitals, government agencies, and managed health care providers. The Animal Health segment develops and markets veterinary pharmaceutical products, vaccines, and health management solutions for livestock and companion animals, selling to veterinarians, distributors, farmers, and pet owners.
Merck is a global health care company operating two main business segments: Pharmaceutical and Animal Health.
What is MRK's valuation?
MRK trades at $151.64, 20.83× trailing earnings, as of 2026-09-03. It carries a 2.15% dividend yield.
When did MRK last file with the SEC?
Merck & Co., Inc.'s most recent SEC filing on record is a 10-Q filed 2026-08-07. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-09-03 10:25 UTC. This page is also available as JSON at /api/data?ticker=MRK and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for MRK and 5,000+ tickers.
